 | • レポートコード：MRC23Q37967 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の麻薬市場について調査・分析し、世界の麻薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AstraZeneca、MPAPHARMA、Johnson & Johnson、Roche、LGC Group、Hikma Pharmaceuticals、Baxter、Maruishi、AuroMedics、Piramal Healthcare、ABbVie、Dechraなどが含まれています。 世界の麻薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、麻薬市場規模を推定する際に考慮しました。本レポートは、麻薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、麻薬に関するビジネス上の意思決定に役立てることを目的としています。 ・麻薬市場の概要 - 製品の定義 - 麻薬のタイプ別セグメント - 世界の麻薬市場規模：タイプ別分析（ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬） - 麻薬の用途別セグメント - 世界の麻薬市場規模：用途別分析（病院、クリニック） - 世界の麻薬市場規模予測（2018年-2029年） - 麻薬の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 麻薬市場の競争状況およびトレンド ・麻薬の地域別市場規模 - 北米の麻薬市場規模（2018年-2029年） - アメリカの麻薬市場規模（2018年-2029年） - ヨーロッパの麻薬市場規模（2018年-2029年） - アジア太平洋の麻薬市場規模（2018年-2029年） - 中国の麻薬市場規模（2018年-2029年） - 日本の麻薬市場規模（2018年-2029年） - 韓国の麻薬市場規模（2018年-2029年） - インドの麻薬市場規模（2018年-2029年） - オーストラリアの麻薬市場規模（2018年-2029年） - 中南米の麻薬市場規模（2018年-2029年） - 中東・アフリカの麻薬市場規模（2018年-2029年） ・タイプ別セグメント：ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬 - 世界の麻薬のタイプ別販売量（2018年-2023年） - 世界の麻薬のタイプ別売上（2018年-2023年） - 世界の麻薬のタイプ別価格 ・用途別セグメント：病院、クリニック - 世界の麻薬の用途別販売量（2018年-2023年） - 世界の麻薬の用途別売上（2018年-2023年） - 世界の麻薬の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 AstraZeneca、MPAPHARMA、Johnson & Johnson、Roche、LGC Group、Hikma Pharmaceuticals、Baxter、Maruishi、AuroMedics、Piramal Healthcare、ABbVie、Dechra ・産業チェーンと販売チャネルの分析 - 麻薬産業チェーン分析 - 麻薬の主要原材料 - 麻薬の販売チャネル - 麻薬のディストリビューター - 麻薬の主要顧客 ・麻薬市場ダイナミクス - 麻薬の業界動向 - 麻薬市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Narcotic Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Narcotic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Narcotic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Narcotic Drugs include AstraZeneca, MPAPHARMA, Johnson & Johnson, Roche, LGC Group, Hikma Pharmaceuticals, Baxter, Maruishi and AuroMedics, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Narcotic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic Drugs.
The Narcotic Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Narcotic Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Narcotic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AstraZeneca
MPAPHARMA
Johnson & Johnson
Roche
LGC Group
Hikma Pharmaceuticals
Baxter
Maruishi
AuroMedics
Piramal Healthcare
ABbVie
Dechra
Segment by Type
Fast Sleep New
Baodingning Mixture
Lumianbao
Other Compound Anesthetics
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Narcotic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Narcotic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Narcotic Drugs Market Overview
1.1 Product Overview and Scope of Narcotic Drugs
1.2 Narcotic Drugs Segment by Type
1.2.1 Global Narcotic Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Fast Sleep New
1.2.3 Baodingning Mixture
1.2.4 Lumianbao
1.2.5 Other Compound Anesthetics
1.3 Narcotic Drugs Segment by Application
1.3.1 Global Narcotic Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Narcotic Drugs Market Size Estimates and Forecasts
1.4.1 Global Narcotic Drugs Revenue 2018-2029
1.4.2 Global Narcotic Drugs Sales 2018-2029
1.4.3 Global Narcotic Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Narcotic Drugs Market Competition by Manufacturers
2.1 Global Narcotic Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Narcotic Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Narcotic Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Narcotic Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Narcotic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Narcotic Drugs, Product Type & Application
2.7 Narcotic Drugs Market Competitive Situation and Trends
2.7.1 Narcotic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Narcotic Drugs Players Market Share by Revenue
2.7.3 Global Narcotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Narcotic Drugs Retrospective Market Scenario by Region
3.1 Global Narcotic Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Narcotic Drugs Global Narcotic Drugs Sales by Region: 2018-2029
3.2.1 Global Narcotic Drugs Sales by Region: 2018-2023
3.2.2 Global Narcotic Drugs Sales by Region: 2024-2029
3.3 Global Narcotic Drugs Global Narcotic Drugs Revenue by Region: 2018-2029
3.3.1 Global Narcotic Drugs Revenue by Region: 2018-2023
3.3.2 Global Narcotic Drugs Revenue by Region: 2024-2029
3.4 North America Narcotic Drugs Market Facts & Figures by Country
3.4.1 North America Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Narcotic Drugs Sales by Country (2018-2029)
3.4.3 North America Narcotic Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Narcotic Drugs Market Facts & Figures by Country
3.5.1 Europe Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Narcotic Drugs Sales by Country (2018-2029)
3.5.3 Europe Narcotic Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Narcotic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Narcotic Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Narcotic Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Narcotic Drugs Market Facts & Figures by Country
3.7.1 Latin America Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Narcotic Drugs Sales by Country (2018-2029)
3.7.3 Latin America Narcotic Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Narcotic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Narcotic Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Narcotic Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Narcotic Drugs Sales by Type (2018-2029)
4.1.1 Global Narcotic Drugs Sales by Type (2018-2023)
4.1.2 Global Narcotic Drugs Sales by Type (2024-2029)
4.1.3 Global Narcotic Drugs Sales Market Share by Type (2018-2029)
4.2 Global Narcotic Drugs Revenue by Type (2018-2029)
4.2.1 Global Narcotic Drugs Revenue by Type (2018-2023)
4.2.2 Global Narcotic Drugs Revenue by Type (2024-2029)
4.2.3 Global Narcotic Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Narcotic Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Narcotic Drugs Sales by Application (2018-2029)
5.1.1 Global Narcotic Drugs Sales by Application (2018-2023)
5.1.2 Global Narcotic Drugs Sales by Application (2024-2029)
5.1.3 Global Narcotic Drugs Sales Market Share by Application (2018-2029)
5.2 Global Narcotic Drugs Revenue by Application (2018-2029)
5.2.1 Global Narcotic Drugs Revenue by Application (2018-2023)
5.2.2 Global Narcotic Drugs Revenue by Application (2024-2029)
5.2.3 Global Narcotic Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Narcotic Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Narcotic Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 MPAPHARMA
6.2.1 MPAPHARMA Corporation Information
6.2.2 MPAPHARMA Description and Business Overview
6.2.3 MPAPHARMA Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 MPAPHARMA Narcotic Drugs Product Portfolio
6.2.5 MPAPHARMA Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Narcotic Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roche Narcotic Drugs Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 LGC Group
6.5.1 LGC Group Corporation Information
6.5.2 LGC Group Description and Business Overview
6.5.3 LGC Group Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LGC Group Narcotic Drugs Product Portfolio
6.5.5 LGC Group Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hikma Pharmaceuticals Narcotic Drugs Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
6.7 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Narcotic Drugs Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Maruishi
6.8.1 Maruishi Corporation Information
6.8.2 Maruishi Description and Business Overview
6.8.3 Maruishi Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Maruishi Narcotic Drugs Product Portfolio
6.8.5 Maruishi Recent Developments/Updates
6.9 AuroMedics
6.9.1 AuroMedics Corporation Information
6.9.2 AuroMedics Description and Business Overview
6.9.3 AuroMedics Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AuroMedics Narcotic Drugs Product Portfolio
6.9.5 AuroMedics Recent Developments/Updates
6.10 Piramal Healthcare
6.10.1 Piramal Healthcare Corporation Information
6.10.2 Piramal Healthcare Description and Business Overview
6.10.3 Piramal Healthcare Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Piramal Healthcare Narcotic Drugs Product Portfolio
6.10.5 Piramal Healthcare Recent Developments/Updates
6.11 ABbVie
6.11.1 ABbVie Corporation Information
6.11.2 ABbVie Narcotic Drugs Description and Business Overview
6.11.3 ABbVie Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ABbVie Narcotic Drugs Product Portfolio
6.11.5 ABbVie Recent Developments/Updates
6.12 Dechra
6.12.1 Dechra Corporation Information
6.12.2 Dechra Narcotic Drugs Description and Business Overview
6.12.3 Dechra Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Dechra Narcotic Drugs Product Portfolio
6.12.5 Dechra Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Narcotic Drugs Industry Chain Analysis
7.2 Narcotic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Narcotic Drugs Production Mode & Process
7.4 Narcotic Drugs Sales and Marketing
7.4.1 Narcotic Drugs Sales Channels
7.4.2 Narcotic Drugs Distributors
7.5 Narcotic Drugs Customers
8 Narcotic Drugs Market Dynamics
8.1 Narcotic Drugs Industry Trends
8.2 Narcotic Drugs Market Drivers
8.3 Narcotic Drugs Market Challenges
8.4 Narcotic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer